News Digest / Ticker: GBLX

Ticker: GBLX

05:14pm, Tuesday, Aug 12, 2025

GB Sciences earns licensing revenue but faces cash crunch, heavy debt and going‑concern risk

Snapshot - GB Sciences, Inc. (OTCMKTS: GBLX) What's happening inside: GB Sciences is a small, IP-heavy biopharma focused on plant‑inspired drug candidates (Parkinson's, chronic pain, MCAS, cardiovascular, CRS). Management is advancing preclinical programs, monetizing IP through a licensing deal w...